Literature DB >> 21940625

Molecular mechanisms of disease for mutations at Gly-90 in rhodopsin.

Darwin Toledo1, Eva Ramon, Mònica Aguilà, Arnau Cordomí, Juan J Pérez, Hugo F Mendes, Michael E Cheetham, Pere Garriga.   

Abstract

Two different mutations at Gly-90 in the second transmembrane helix of the photoreceptor protein rhodopsin have been proposed to lead to different phenotypes. G90D has been classically associated with congenital night blindness, whereas the newly reported G90V substitution was linked to a retinitis pigmentosa phenotype. Here, we used Val/Asp replacements of the native Gly at position 90 to unravel the structure/function divergences caused by these mutations and the potential molecular mechanisms of inherited retinal disease. The G90V and G90D mutants have a similar conformation around the Schiff base linkage region in the dark state and same regeneration kinetics with 11-cis-retinal, but G90V has dramatically reduced thermal stability when compared with the G90D mutant rhodopsin. The G90V mutant also shows, like G90D, an altered photobleaching pattern and capacity to activate Gt in the opsin state. Furthermore, the regeneration of the G90V mutant with 9-cis-retinal was improved, achieving the same A(280)/A(500) as wild type isorhodopsin. Hydroxylamine resistance was also recovered, indicating a compact structure around the Schiff base linkage, and the thermal stability was substantially improved when compared with the 11-cis-regenerated mutant. These results support the role of thermal instability and/or abnormal photoproduct formation in eliciting a retinitis pigmentosa phenotype. The improved stability and more compact structure of the G90V mutant when it was regenerated with 9-cis-retinal brings about the possibility that this isomer or other modified retinoid analogues might be used in potential treatment strategies for mutants showing the same structural features.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940625      PMCID: PMC3220564          DOI: 10.1074/jbc.M110.201517

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Protein assistance in the photoisomerization of rhodopsin and 9-cis-rhodopsin--insights from experiment and theory.

Authors:  Sivakumar Sekharan; Minoru Sugihara; Oliver Weingart; Tetsuji Okada; Volker Buss
Journal:  J Am Chem Soc       Date:  2007-02-07       Impact factor: 15.419

2.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

Review 3.  Structural models of class a G protein-coupled receptors as a tool for drug design: insights on transmembrane bundle plasticity.

Authors:  Xavier Deupi; Nicole Dölker; María Luz López-Rodríguez; Mercedes Campillo; Juan A Ballesteros; Leonardo Pardo
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 4.  Conformational diseases: looking into the eyes.

Authors:  Alexei Surguchev; Andrei Surguchov
Journal:  Brain Res Bull       Date:  2010-01-15       Impact factor: 4.077

5.  The role of transmembrane segment II in 7TM receptor activation.

Authors:  T Benned-Jensen; M M Rosenkilde
Journal:  Curr Mol Pharmacol       Date:  2009-06       Impact factor: 3.339

6.  Two protonation switches control rhodopsin activation in membranes.

Authors:  Mohana Mahalingam; Karina Martínez-Mayorga; Michael F Brown; Reiner Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-07       Impact factor: 11.205

7.  Night blindness and the mechanism of constitutive signaling of mutant G90D rhodopsin.

Authors:  Alexander M Dizhoor; Michael L Woodruff; Elena V Olshevskaya; Marianne C Cilluffo; M Carter Cornwall; Paul A Sieving; Gordon L Fain
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

8.  A dual role for EDEM1 in the processing of rod opsin.

Authors:  Maria Kosmaoglou; Naheed Kanuga; Mònica Aguilà; Pere Garriga; Michael E Cheetham
Journal:  J Cell Sci       Date:  2009-11-24       Impact factor: 5.285

9.  Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa.

Authors:  Hugo F Mendes; Michael E Cheetham
Journal:  Hum Mol Genet       Date:  2008-07-17       Impact factor: 6.150

10.  Constitutive excitation by Gly90Asp rhodopsin rescues rods from degeneration caused by elevated production of cGMP in the dark.

Authors:  Michael L Woodruff; Elena V Olshevskaya; Andrey B Savchenko; Igor V Peshenko; Ronald Barrett; Ronald A Bush; Paul A Sieving; Gordon L Fain; Alexander M Dizhoor
Journal:  J Neurosci       Date:  2007-08-15       Impact factor: 6.167

View more
  19 in total

1.  Structural, energetic, and mechanical perturbations in rhodopsin mutant that causes congenital stationary night blindness.

Authors:  Shiho Kawamura; Alejandro T Colozo; Lin Ge; Daniel J Müller; Paul S-H Park
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

2.  Insights into congenital stationary night blindness based on the structure of G90D rhodopsin.

Authors:  Ankita Singhal; Martin K Ostermaier; Sergey A Vishnivetskiy; Valérie Panneels; Kristoff T Homan; John J G Tesmer; Dmitry Veprintsev; Xavier Deupi; Vsevolod V Gurevich; Gebhard F X Schertler; Joerg Standfuss
Journal:  EMBO Rep       Date:  2013-04-12       Impact factor: 8.807

3.  Zinc Is Involved in Depression by Modulating G Protein-Coupled Receptor Heterodimerization.

Authors:  Mercè Tena-Campos; Eva Ramon; Cecylia S Lupala; Juan J Pérez; Karl-W Koch; Pere Garriga
Journal:  Mol Neurobiol       Date:  2015-04-09       Impact factor: 5.590

Review 4.  The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.

Authors:  Dimitra Athanasiou; Monica Aguila; James Bellingham; Wenwen Li; Caroline McCulley; Philip J Reeves; Michael E Cheetham
Journal:  Prog Retin Eye Res       Date:  2017-10-16       Impact factor: 21.198

5.  Differential light-induced responses in sectorial inherited retinal degeneration.

Authors:  Eva Ramon; Arnau Cordomí; Mònica Aguilà; Sundaramoorthy Srinivasan; Xiaoyun Dong; Anthony T Moore; Andrew R Webster; Michael E Cheetham; Pere Garriga
Journal:  J Biol Chem       Date:  2014-10-30       Impact factor: 5.157

Review 6.  Constitutively active rhodopsin and retinal disease.

Authors:  Paul Shin-Hyun Park
Journal:  Adv Pharmacol       Date:  2014

7.  Structural role of the T94I rhodopsin mutation in congenital stationary night blindness.

Authors:  Ankita Singhal; Ying Guo; Milos Matkovic; Gebhard Schertler; Xavier Deupi; Elsa Cy Yan; Joerg Standfuss
Journal:  EMBO Rep       Date:  2016-07-25       Impact factor: 8.807

8.  Retinal degeneration in mice expressing the constitutively active G90D rhodopsin mutant.

Authors:  Alejandro T Colozo; Sreelakshmi Vasudevan; Paul S-H Park
Journal:  Hum Mol Genet       Date:  2020-04-15       Impact factor: 6.150

Review 9.  Endoplasmic reticulum stress: New insights into the pathogenesis and treatment of retinal degenerative diseases.

Authors:  Marina S Gorbatyuk; Christopher R Starr; Oleg S Gorbatyuk
Journal:  Prog Retin Eye Res       Date:  2020-04-06       Impact factor: 21.198

10.  Model of Abnormal Chromophore-Protein Interaction for Е181К Rhodopsin Mutation: Computer Molecular Dynamics Study.

Authors:  Tatyana Feldman; Mikhail Ostrovsky; Kholmirzo Kholmurodov; Kenji Yasuoka
Journal:  Open Biochem J       Date:  2012-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.